ZIOPHARM ONCOLOGY INC (ZIOP) is a publicly traded company in the Unknown sector. Across all available filings, 37 corporate insiders have executed 318 transactions totaling $69.6M, demonstrating a bullish sentiment with $59.0M in net insider flow. The most recent transaction on Dec 22, 2021 involved a sale of 20,132 shares valued at $25.6K.
No significant insider buying has been recorded for ZIOP in the recent period.
No significant insider selling has been recorded for ZIOP in the recent period.
Based on recent SEC filings, insider sentiment for ZIOP is bullish with an Insider Alignment Score of 92/100 and a net flow of $59.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ZIOPHARM ONCOLOGY INC (ZIOP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 37 insiders are actively trading ZIOP stock, having executed 318 transactions in the past 90 days. The most active insider is Corp Intrexon (Executive), who has made 36 transactions totaling $38.5M.
Get notified when executives and directors at ZIOP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Eleanor De Groot | Executive | Sale | 20,132 | $1.27 | $25.6K | |
| Nov 17, 2021 | S. Boyle Kevin Sr | Executive | Purchase | 9,116 | $1.40 | $12.8K | |
| Nov 16, 2021 | S. Boyle Kevin Sr | Executive | Purchase | 884 | $1.40 | $1.2K | |
| Sep 29, 2021 | Vieser Jaime | Executive | Purchase | 100,000 | $1.91 | $191.0K | |
| Sep 2, 2021 | W. Postma Robert | Executive | Purchase | 54,492 | $1.73 | $94.3K | |
| Sep 2, 2021 | W. Postma Robert | Executive | Purchase | 20,508 | $1.73 | $35.5K | |
| Sep 2, 2021 | Hagen Heidi | Executive | Purchase | 23,770 | $1.76 | $41.8K | |
| Sep 1, 2021 | Huang James | Executive | Purchase | 100,000 | $1.71 | $171.0K | |
| Sep 1, 2021 | Weis Holger | Executive | Purchase | 50,000 | $1.83 | $91.5K | |
| Aug 30, 2021 | S. Boyle Kevin Sr | Executive | Award | 875,000 | $N/A | $0 | |
| May 17, 2021 | Baffa Raffaele | Executive | Award | 80,645 | $N/A | $0 | |
| Mar 4, 2021 | Bowden Christopher | Executive | Award | 4,167 | $N/A | $0 | |
| Mar 4, 2021 | Kevin Buchi J. | Executive | Award | 4,167 | $N/A | $0 | |
| Mar 4, 2021 | Huang James | Executive | Award | 8,333 | $N/A | $0 | |
| Mar 4, 2021 | W. Postma Robert | Executive | Award | 2,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 33 | $64.3M | 71.1% |
Award(A) | 118 | $10.3M | 11.3% |
Payment(F) | 88 | $8.0M | 8.9% |
Sale(S) | 22 | $5.3M | 5.9% |
Exercise(M) | 22 | $1.7M | 1.9% |
Exercise (Options)(X) | 5 | $525.8K | 0.6% |
Other(J) | 28 | $303.7K | 0.3% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at ZIOPHARM ONCOLOGY INC are accumulating shares at an accelerated pace. With 37 insiders making 318 transactions totaling $64.3M in purchases versus $5.3M in sales, the net buying activity of $59.0M signals strong executive confidence. Corp Intrexon (Executive) leads the buying activity with $38.5M in transactions across all time.